{"id":"0c08a628-e850-46cf-8942-fdf91fcc9e05","modelId":"5a1c4db9-069d-4fdb-8ace-9917a3255ed1","versionId":null,"locationId":"aa8b9c05-c836-4021-801f-59801970401e","operatorId":null,"ownerId":null,"slug":"cyberdyne-hal-united-states","status":"active","firstSeen":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.cyberdyne.jp/english/company/PressReleases_detail.html?id=14303","title":"Tochigi Robocare Opens ~18th Robocare Center in Japan","sourceName":"Cyberdyne"},{"url":"https://www.fda.gov/medical-devices/recently-approved-devices/cyberdyne-hal-510k","title":"Cyberdyne HAL FDA 510(k) clearance","sourceName":"FDA"}],"notes":"Cyberdyne operates fee-based medical HAL services in the US through subsidiary RISE Healthcare Group at 5 Southern California locations. FDA clearance covers SCI, stroke, progressive neuromuscular diseases, and cerebral palsy (ages 12+). Carnegie Mellon University MOU signed December 2025 to accelerate US social implementation.","keyFacts":[{"label":"FDA status","value":"FDA cleared for SCI, stroke, 8 progressive neuromuscular diseases, cerebral palsy (ages 12+), HAM, hereditary spastic paraplegia"},{"label":"US clinical sites","value":"RISE Healthcare Group operates 5 fee-based medical locations in Southern California"},{"label":"CMU partnership","value":"Strategic MOU with Carnegie Mellon University signed December 2025 for US social implementation"}],"reviewNote":null,"exposureHours":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-06-07T13:21:37.246Z","updatedAt":"2026-06-07T14:42:41.217Z","model":{"id":"5a1c4db9-069d-4fdb-8ace-9917a3255ed1","companyId":"e6c82ae9-e819-484a-8b07-cabfbe90e3cc","modelName":"Cyberdyne HAL","slug":"cyberdyne-hal","description":"Powered (motor-driven) exoskeleton whose distinguishing feature is bioelectric-signal control: skin-surface sensors detect the faint nerve/muscle signals of intended movement and drive the actuators in sync. Medical lower-limb version FDA cleared 2017; clinical use in Japan since 2008.","formFactor":"exoskeleton","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"use":"medical rehab","control":"bioelectric-signal (skin-surface intention sensing)","powered":"yes (motor-driven)","regulatory":"FDA cleared 2017 (medical lower-limb)","body_region":"lower-limb (also full-body variants)","availability":"commercial"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://en.wikipedia.org/wiki/Cyberdyne_Inc.","title":"Cyberdyne HAL","sourceName":"Wikipedia"},{"url":"https://www.borntoengineer.com/cyberdyne-japanese-exoskeleton-gets-fda-approval","title":"Cyberdyne HAL FDA approval","sourceName":"Born to Engineer"}],"aliases":["HAL","Hybrid Assistive Limb"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"createdAt":"2026-06-06T01:25:41.568Z","updatedAt":"2026-06-06T02:44:44.266Z","company":{"id":"e6c82ae9-e819-484a-8b07-cabfbe90e3cc","name":"Cyberdyne","slug":"cyberdyne","description":"Japanese cybernics company (founded 2004). HAL (Hybrid Assistive Limb) is a powered exoskeleton that reads bioelectric signals from the user's skin to drive its motors.","status":"public (TSE: 7779)","founded":2004,"hq":"Tsukuba, Japan","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","sources":[{"url":"https://en.wikipedia.org/wiki/Cyberdyne_Inc.","title":"Cyberdyne","sourceName":"Wikipedia"},{"url":"https://www.borntoengineer.com/cyberdyne-japanese-exoskeleton-gets-fda-approval","title":"Cyberdyne HAL FDA approval","sourceName":"Born to Engineer"}],"keyFacts":[],"aliases":["Cyberdyne Inc"],"collisionRisk":"low","reviewNote":null,"createdAt":"2026-06-06T01:25:38.275Z","updatedAt":"2026-06-06T02:17:59.528Z"}},"version":null,"location":{"id":"aa8b9c05-c836-4021-801f-59801970401e","name":"United States","slug":"united-states","kind":"country","parentLocationId":null,"lat":null,"lng":null,"reviewStatus":"reviewed","aliases":["USA","US","United States of America"],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-05-30T22:00:33.148Z","updatedAt":"2026-05-30T22:00:33.148Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/cyberdyne-hal-united-states","url":"https://registry.deploy.report/deployments/cyberdyne-hal-united-states","name":"Cyberdyne HAL at United States","identifier":"0c08a628-e850-46cf-8942-fdf91fcc9e05","eventStatus":"https://schema.org/EventScheduled","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/united-states","name":"United States"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/cyberdyne","name":"Cyberdyne"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/cyberdyne-hal","name":"Cyberdyne HAL"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"exoskeleton","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":["primary-fda-database"]}}}